Skip to main content
Skip to main navigation
Invalid credentials.
Search for :
Product Development Strategy
Early Clinical Development
Phase I/IIa Clinical Trials
Phase II/III Clinical Trials
Interventional Phase IIIb/Phase IV Clinical Trials
Observational Research & Registries
Product Launch & Management
Market Access Solutions
Strategic Sales Outsourcing
Biopharmaceutical R&D
Biopharmaceutical Sales & Marketing
Biosimilars
Healthcare Payers & Providers
Medical Device & Diagnostics
Public Health & Government
Cardiovascular
Central Nervous System
Diabetes & Endocrinology
Infectious Diseases
Internal Medicine
Oncology
Early Phase Oncology
Translational Oncology
Pediatrics
Public Health Interest
Vaccines
Other Therapeutic Areas
Our Focus
Our Values
Our Heritage
Our Perspectives
Our Leadership
Ethics & Compliance
Investors
Global Locations
Facebook Twitter LinkedIn YouTube
Local Resources: Access to Patients, Clinical, ProductMarketing & Sales, Data ManagementBiostatistics, Project ManagementSafety, Regulatory
Operating since: 1996
Patients enrolled: 200,000 - 250,000 in North America (2004-2008)
Studies 200,000-250,000 in Asia (2004-2008)
Workforce: 5,000 - 10,000 in North America (12/31/08)
Go to Canada
Local Resources: Clinical, Product Marketing& Sales, Regulatory
Operating since: 1997
Studies >750 in North America (2004-2008)
Go to Mexico
Local Resources: Access to Patients, Central Lab Clinical, Product Marketing & SalesConsulting & Partnering, Data ManagementBiostatistics, Phase I, Project ManagementSafety, Regulatory
Operating since: 1982
Go to United States
Quintiles’ approach to risk based monitoring, powered by Infosario™, increases monitoring efficiency by applying the correct trial management strategy and resource allocations on the most critical data and functions that pose the highest risk to achieving your goals. Read more
As healthcare decision making becomes more complex, stakeholders are demanding real-world evidence tailored to their own individual needs. Read white paper
The work we do with the biopharmaceutical industry, payers and providers has a profound effect on extending patients’ lives and quality of life around the world. Learn More About Quintiles